[Form 4] QUEST DIAGNOSTICS INC Insider Trading Activity
Quest Diagnostics director reports small stock sale A director of Quest Diagnostics Inc. reported selling 1,250 shares of common stock on 11/25/2025 at a price of $191.76 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Quest Diagnostics director reports small stock sale
A director of Quest Diagnostics Inc. reported selling 1,250 shares of common stock on 11/25/2025 at a price of $191.76 per share. This insider now directly owns 17,037 Quest Diagnostics shares after the transaction. The filing is a Form 4 submitted for board member Vicky B. Gregg, with the form signed by an attorney-in-fact.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,250 | $191.76 | $240K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Quest Diagnostics (DGX) disclose?
What form was filed for the Quest Diagnostics (DGX) insider trade?
What is the role of the reporting person at Quest Diagnostics (DGX)?
Who signed the Quest Diagnostics (DGX) Form 4 for this transaction?
Did the Quest Diagnostics (DGX) Form 4 include any derivative securities activity?
AI-generated analysis. How Rhea-AI works. Not financial advice.